Targeting of the hNC16A collagen domain to dendritic cells induces tolerance to human type XVII collagen

Experimental Dermatology

Volumn 21, Issue 5, 2012, Pages 395-398

  Ettinger, Monika ^a   Gratz, Iris K ^a,b   Gruber, Christina ^a   Hauser Kronberger, Cornelia ^a   Johnson, Theron S ^c   Mahnke, Karsten ^d   Thalhamer, Josef ^e   Hintner, Helmut ^a   Peckl Schmid, Doris ^a   Bauer, Johann W ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF SALZBURG   (Austria)

Author keywords

BP180; DEC205; Skin grafting; Tolerance induction; Type XVII collagen

Indexed keywords

ANTIBODY; COLLAGEN TYPE 16; COLLAGEN TYPE 17;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE ASSOCIATION; GENETIC ENGINEERING; GENETIC TRANSFECTION; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; LETTER; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PLASMID; PROTEIN DOMAIN; SKIN GRAFT; SKIN TRANSPLANTATION; SURVIVAL TIME;

ANIMALS; AUTOANTIGENS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; GENETIC THERAPY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNE TOLERANCE; LANGERHANS CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, ANIMAL; NON-FIBRILLAR COLLAGENS; PROTEIN STRUCTURE, TERTIARY; SKIN TRANSPLANTATION; TRANSFECTION;

EID: 84859899776     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01474.x     Document Type: Letter

References (18)

1. Franzke C W, Bruckner P, Bruckner-Tuderman L. J Biol Chem 2005: 280: 4005-4008.
2. Nievers M G, Schaapveld R Q, Sonnenberg A. Matrix Biol 1999: 18: 5-17.
3. Powell A M, Sakuma-Oyama Y, Oyama N et al. Clin Exp Dermatol 2005: 30: 682-687.
4. Bauer J W, Lanschuetzer C. Clin Exp Dermatol 2003: 28: 53-60.
5. Laimer M, Bauer J W, Klausegger A et al. Br J Dermatol 2006: 154: 185-187.
6. Ujiie H, Shibaki A, Nishie W et al. J Dermatol 2010: 37: 194-204.
7. Zillikens D, Giudice G J. Arch Dermatol Res 1999: 291: 187-194.
8. Zillikens D, Rose P A, Balding S D et al. J Invest Dermatol 1997: 109: 573-579.
9. Horvath B, Niedermeier A, Podstawa E et al. Exp Dermatol 2010: 19: 648-653.
10. Ishiura N, Fujimoto M, Watanabe R et al. J Dermatol Sci 2008: 49: 153-161.
11. Bonifaz L, Bonnyay D, Mahnke K et al. J Exp Med 2002: 196: 1627-1638.
12. Hawiger D, Inaba K, Dorsett Y et al. J Exp Med 2001: 194: 769-779.
13. Mahnke K, Guo M, Lee S et al. J Cell Biol 2000: 151: 673-684.
14. Mahnke K, Qian Y, Knop J et al. Blood 2003: 101: 4862-4869.
15. Olasz E B, Roh J, Yee C L et al. J Invest Dermatol 2007: 127: 2807-2817.
16. Hutchinson I V. Transplantation 1986: 41: 547-555.
17. Gilliet M, Liu Y J. J Exp Med 2002: 195: 695-704.
18. Zhou J, Carr R I, Liwski R S et al. J Immunol 2001: 167: 107-113.